Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

par William John Yaxley, Rhiannon McBean, David Wong, David Grimes, Paul Vasey, Mark Frydenberg, John William Yaxley
Publié 2021

The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signali...

par Chen Wang, Na Zhao, Fuyuki Sato, Keiji Tanimoto, Hiroyuki Okada, Yang Liu, Ujjal K. Bhawal
Publié 2021

Type of treatment, symptoms and patient satisfaction play an important role in primary care contact during prostate cancer follow-up: results from the population-based PROFILES reg...

par Barbara M. Wollersheim, Mies van Eenbergen, Kristel M. van Asselt, Laurent M. C. L. Fossion, Evert L. Koldewijn, Jorg R. Oddens, Eric H. Oomens, Bart P. Wijsman, Lonneke V. van de Poll-Franse, Nicole P. M. Ezendam
Publié 2021

CircSERPINA3 regulates SERPINA3-mediated apoptosis, autophagy and aerobic glycolysis of prostate cancer cells by competitively binding to MiR-653-5p and recruiting BUD13

par Zengshu Xing, Sailian Li, Zhenxiang Liu, Chong Zhang, Zhiming Bai
Publié 2021

Accurate diagnosis of prostate cancer using logistic regression

par Hooshmand Arash
Publié 2021

Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution pros...

par Jorgo Kliton, Polgar Csaba, Stelczer Gabor, Major Tibor, Gesztesi Laszlo, Agoston Peter
Publié 2021

Loss of SELENOF Induces the Transformed Phenotype in Human Immortalized Prostate Epithelial Cells

par Lenny K. Hong, Shrinidhi Kadkol, Maria Sverdlov, Irida Kastrati, Mostafa Elhodaky, Ryan Deaton, Karen S. Sfanos, Heidi Wang, Li Liu, Alan M. Diamond
Publié 2021

Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands

par Rachel N. Flach, Peter-Paul M. Willemse, Britt B. M. Suelmann, Ivette A. G. Deckers, Trudy N. Jonges, Carmen van Dooijeweert, Paul J. van Diest, Richard P. Meijer
Publié 2021

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC

par Lilv Fan, Guiliang Xu, Jingjing Cao, Min Li, Huihui Zhang, Fanlin Li, Xinyue Qi, Xiaoqing Zhang, Zeyu Li, Ping Han, Xuanming Yang
Publié 2021

Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel

par Minami Une, Kosuke Takemura, Kentaro Inamura, Hiroshi Fukushima, Masaya Ito, Shuichiro Kobayashi, Takeshi Yuasa, Junji Yonese, Philip G. Board, Fumitaka Koga
Publié 2021

Men’s perception of information and descriptions of emotional strain in the diagnostic phase of prostate cancer—a qualitative individual interview study

par Maja Elisabeth Juul Søndergaard, Kirsten Lode, Svein Reidar Kjosavik, Sissel Eikeland Husebø
Publié 2021

Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity

par Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, Antonio Gómez-Caamaño, Raquel García-Gómez, Asunción Hervás Morón
Publié 2021

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

par Andrew Bakshi, Moeen Riaz, Suzanne G. Orchard, Prudence R. Carr, Amit D. Joshi, Yin Cao, Richard Rebello, Tú Nguyen-Dumont, Melissa C. Southey, Jeremy L. Millar, Lucy Gately, Peter Gibbs, Leslie G. Ford, Howard L. Parnes, Andrew T. Chan, John J. McNeil, Paul Lacaze
Publié 2021

The Cardiac Glycoside Deslanoside Exerts Anticancer Activity in Prostate Cancer Cells by Modulating Multiple Signaling Pathways

par Mingcheng Liu, Qingqing Huang, Jun A, Linyue Li, Xiawei Li, Zhiqian Zhang, Jin-Tang Dong
Publié 2021

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patient...

par Paola Mapelli, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Giorgio Brembilla, Vito Cucchiara, Naghia Ahmed, Carolina Bezzi, Luca Presotto, Valentino Bettinardi, Annarita Savi, Patrizia Magnani, Raffaele Menichini, Angela Coliva, Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Massimo Freschi, Alberto Briganti, Francesco De Cobelli, Paola Scifo, Maria Picchio
Publié 2021

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer

par Mohammad Taheri, Tayyebeh Khoshbakht, Elena Jamali, Julia Kallenbach, Soudeh Ghafouri-Fard, Aria Baniahmad
Publié 2021

Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S

par Pan J, Shao X, Zhu Y, Dong B, Wang Y, Kang X, Chen N, Chen Z, Liu S, Xue W
Publié 2019

The central role of NADPH depletion in MnTE-2-PyP-induced prostate cancer cell growth inhibition

par Yuxiang Zhu, Divya Murthy, Sai Sundeep Kollala, Elizabeth A. Kosmacek, Arpita Chatterjee, Joshua A. McDowell, Pankaj K. Singh, Rebecca E. Oberley-Deegan
Publié 2021

Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer

par Wu M, Wang Y, Wang YR, Zhang MB, Luo YK, Tang J, Wang ZG, Wang D, Hao L, Wang ZB
Publié 2017

Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery

par Hou CP, Chen TY, Chang CC, Lin YH, Chang PL, Chen CL, Hsu YC, Tsui KH
Publié 2013